Recent news and posts
The 2022 list of medical technologies approved for innovation funding (NUB) released in Germany
On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021.
Out of 868 submitted technologies, 251 (29%) received the positive status 1, which means that the suggested procedure or medical device met the NUB criteria, so now the hospitals can negotiate the innovation funding for these technologies with the sickness funds.
Furthermore, 32 (4%) technologies received differentiated status, which means that status 1 can be granted only under certain conditions.
The complete list of medical technologies (n=84, excluding pharmaceuticals), which obtained status 1, is provided below. The technologies are listed according to the number of received applications for funding. The technologies with differentiated status were not included in the list.
- Insertion of coated (covered) stents with the bioactive surface for peripheral vessels
- Covered endoprostheses with the bioactive surface for dialysis shunt revision
- Ascites treatment with a fully implantable pump
- External stabilization scaffold for anastomosis of an AV shunt as part of shunt surgery
- Endovascular placement of an internal AV shunt using magnetically guided high-frequency energy
- Intra-aortic catheter with paracorporeal membrane pump for circulatory support
- Flow-reducing wire mesh in the coronary sinus
- Hemodynamically effective implant for the endovascular treatment of intracranial aneurysms and cervical vessels supplying the brain
- Intraaneurysmal hemodynamically effective implant for the endovascular treatment of intracranial aneurysms
- Removable, ultra-soft microcoils for intracranial therapy of vascular malformations and aneurysms
- Transcatheter implantation of an interatrial shunt device for the treatment of heart failure
- Percutaneous transluminal insertion of an atrial septal implant for the treatment of heart failure
- Implantation of a gastric pacemaker
- Extracorporeal neurostimulation system for the peripheral nervous system
- Endovascular implantation of an extracorporeal centrifugal pump for circulatory support
- Focal photodynamic therapy with padeliporfin for the treatment of localized prostate cancer
- Administration of CAR-T cells for the treatment of hematological diseases
- Therapy of scoliosis using magnetically controlled rods
- Vertebral bodies growth modulation technique
- Transfer of virus-specific donor immune cells after allogeneic stem cell transplantation
- Endovascular mitral valve annuloplasty with annuloplasty band
- Transapical mitral valve reconstruction via implantation of neochordae (polytetrafluoroethylene, PTFE)
- Temporomandibular joint endoprosthesis (total replacement)
- Mesenchymal stem cells
- Minimally invasive left ventricle reconstruction with a myocardial anchoring system
- Percutaneous caval valve stent placement
- Intra-aortic balloon occlusion with extracorporeal circulation
- The wireless cardiac pacing system of the left ventricle for cardiac resynchronization therapy
- Insertion of coated (covered) stents with the bioactive surface for peripheral and other vessels
- Catheter-based implant for the treatment of left ventricular cardiac motility disorders
- Percutaneous transluminal implantation of an interatrial shunt for the treatment of heart failure with preserved or reduced left ventricular ejection fraction
- Therapy of scoliosis using a screw-rod system that grows with the patient
- Endovascular placement of a peripheral AV fistula by direct current
- Insertion of coated (covered) stents with a bioactive surface for intra-abdominal, cranial, or peripheral vessels
- Implantation of a heart valve that grows with the patient
- Endo-Exo prosthesis
- Endovascular implantation of a stent-graft with valve element in tricuspid valve insufficiency
- Replacement of the pulmonary trunk or parts of the aorta with an acellular allograft
- Thrombectomy of pulmonary vessels using the disc retriever system
- Performing a sleeve resection, endoscopically
- Radioligand therapy with Actinium-225-PSMA ligands
- Insertion of a colorectal bypass system to protect the anastomosis
- Radioimmunotherapy with anti-CD19, anti-CD45, and anti-CD66 antibodies
- Endoscopic intratumoral injection of phosphorus-32-labeled microparticles under ultrasound guidance in irresectable locally advanced pancreatic tumors
- Mesenchymal stem cells in therapy-resistant venous ulcers
- Apicoaortal, valve-bearing conduit
- Implant for direct acoustic stimulation of the cochlea (DACI)
- Insertion of coated (covered) stents with the bioactive surface for visceral and supra-aortic vessels
- Endoscopic thermal ablation of the duodenal mucosa to reduce insulin resistance
- Fetoscopic drainage therapy
- Continuous amniotic infusion using a subcutaneously implanted port system
- Acoustic neurinoma surgery with simultaneous cochlea implantation
- Endovascular mitral valve annuloplasty with anchorage of the suture
- Implantation of an intraocular lens with a magnification factor in macular degeneration
- Thyroplasty implant with the possibility of postoperative adjustment of vocal fold position
- Epiretinal retinal prosthesis
- Fetoscopic tracheal balloon closure in diaphragmatic hernia and premature rupture of the membranes
- Lutetium-177- or Yttrium-90 Pentixafor therapy
- Intracavitary radiotherapy with iodine-125
- Telemetrically adjustable pulmonary artery banding
- Closure of umbilical cord and intrafetal vessels using percutaneous ultrasound-guided radiofrequency ablation or fetoscopic laser ablation
- Boston keratoprosthesis
- Fetoscopic opening of narrowed semilunar valves and the foramen ovale
- Auditory brainstem implant
- Fetoscopic therapy of fetal supraventricular tachycardia and occlusion of the larynx or trachea
- Keratoprosthesis, biologically coated
- Uterine shield closure after fetoscopic surgery
- Growth endoprostheses
- Allogeneic hepatocyte transplantation
- Percutaneous transthoracic tricuspid valve replacement
- Radionuclide therapy with lutetium-177-bisphosphonate in bone metastases of prostate cancer
- Auditory middle brain implant
- Artificial larynx after total laryngectomy
- Radionuclide therapy with iodine-131-azetidinylamide in metastatic adrenal carcinoma
- Subretinal active implant
- Uterus transplantation
- Treatment of lethal epidermolysis bullosa junctionalis (M. Herlitz type) by transplanting haploidentical bone marrow and skin from the same donor
- Treatment of children with rhabdomyosarcomas of the bladder/prostate/rectum/perineal region with organ-preserving surgery and interstitial HDR brachytherapy
- Joint transplantations with thin-layered, fresh, living, allogeneic cartilage or bone material
- Gene therapy with autologous CD34+ enriched cells with ARSAGs for the treatment of metachromatic leukodystrophy
- Implantation of an intraocular lens in patients with macular diseases
- Combined renal and stem cell transplantation (living donation)
- Radionuclide therapy with iodine-131 metomidate
- Complete face transplantation
Seven new technologies (thrombectomy of pulmonary vessels using the disc retriever system, insertion of a colorectal bypass system to protect the anastomosis, endoscopic-intratumoral injection of phosphorus-32-labeled microparticles under ultrasound guidance in irresectable locally advanced pancreatic tumors, mesenchymal stem cells in therapy-resistant venous ulcers, endoscopic thermal ablation of the duodenal mucosa to reduce insulin resistance, implantation of an intraocular lens with a magnification factor in macular degeneration, implantation of an intraocular lens in patients with macular diseases) received status 1 in comparison with the 2021 list.
The full details in German can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.